Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
about
Qualification and application of an ELISA for the determination of Tamm Horsfall protein (THP) in human urine and its use for screening of kidney stone diseaseThe elementome of calcium-based urinary stones and its role in urolithiasisEvaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size.Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?Elemental Content of Calcium Oxalate Stones from a Canine Model of Urinary Stone DiseaseEvaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy in children with urolithiasisWu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial.Association Study of Reported Significant Loci at 5q35.3, 7p14.3, 13q14.1 and 16p12.3 with Urolithiasis in Chinese Han EthnicityCalcium renal lithiasis: metabolic diagnosis and medical treatment.Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study.Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysisAssociation of interleukin-18 gene polymorphisms with calcium oxalate kidney stone disease.Assessment of mineral intake by kidney stone patients of Kangra District, Himachal Pradesh with respect to their gender, age and income.Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis.Oxalate synthesis in leaves is associated with root uptake of nitrate and its assimilation in spinach (Spinacia oleracea L.) plants.Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.
P2860
Q24647981-DDC175AB-C9CB-4C91-A638-F17C568ED86CQ26786250-C718AAEF-FAAF-4994-B900-B09AA22DB70BQ30367714-8075032B-A0DD-434C-916B-114EAE06E0C6Q33762199-C9E288C3-597D-447D-996E-AECF29D78139Q35661301-B1A1EF57-DC87-40E8-8928-C79096EB99A3Q36422649-E9B40AEE-EC95-48E9-B1BB-68F796E4E082Q37357212-A4F05268-09B8-4A9B-80CE-E01558BFEFE5Q37731634-890972A6-6DB2-41EF-8EA8-4B37152868C9Q38094025-401B8FF1-4C05-4892-8FCE-6D3DF3D7722CQ39117987-E87D0B46-0E2D-4551-9296-F00640E6A793Q41896847-5D110967-3DCC-4A4A-9065-2EECC8D58D48Q43217443-784C3978-9BD5-4382-B15D-8A260C742E54Q51258430-3FFFA73B-A03B-4BA3-986F-9244D0B62649Q51358477-91312828-0EDB-453C-B989-F3CAFC6568AEQ51407486-73686195-8C0E-4CE3-93A3-FE74667C4346Q54333718-52E0198C-A76A-4BF8-AEE5-DD895C42D439
P2860
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@ast
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@en
type
label
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@ast
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@en
prefLabel
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@ast
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@en
P1433
P1476
Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.
@en
P2093
Allen L Rodgers
Sonja Lewandowski
P356
10.1016/J.CCCN.2004.03.009
P577
2004-07-01T00:00:00Z